Eurofins-Cerep (XPAR:ALECR) Total Liabilities : €12.32 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep Total Liabilities?

Eurofins-Cerep's Total Liabilities for the quarter that ended in Dec. 2024 was €12.32 Mil.

Eurofins-Cerep's quarterly Total Liabilities declined from Dec. 2023 (€14.63 Mil) to Jun. 2024 (€10.86 Mil) but then increased from Jun. 2024 (€10.86 Mil) to Dec. 2024 (€12.32 Mil).

Eurofins-Cerep's annual Total Liabilities increased from Dec. 2022 (€14.12 Mil) to Dec. 2023 (€14.63 Mil) but then declined from Dec. 2023 (€14.63 Mil) to Dec. 2024 (€12.32 Mil).

Eurofins-Cerep Total Liabilities Historical Data

The historical data trend for Eurofins-Cerep's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins-Cerep Total Liabilities Chart

Eurofins-Cerep Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

10.95

14.35

14.12

14.63

12.32

Eurofins-Cerep Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															14.12	12.53	14.63	10.86	12.32

Eurofins-Cerep Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eurofins-Cerep's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.467	+	(0	+	1.856
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	12.32

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	84.063	-	71.74
	=	12.32

Eurofins-Cerep's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.467	+	(0	+	1.856
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	12.32

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	84.063	-	71.74
	=	12.32

Eurofins-Cerep Total Liabilities Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurofins-Cerep Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Le bois l Eveque, Celle l Evescault, FRA, 86600

Website

http://www.cerep.fr

Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.

Eurofins-Cerep Headlines

No Headlines